
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol. , 29 October 2020
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.569584
This article is part of the Research Topic Novel Diagnostic and Therapeutic Strategies in the Management of Cerebral Gliomas View all 55 articles
A retraction of this article was approved in:
Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT
Citation: Zhang Q, Yang L, Guan G, Cheng P, Cheng W and Wu A (2020) LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT. Front. Oncol. 10:569584. doi: 10.3389/fonc.2020.569584
Received: 04 June 2020; Accepted: 05 October 2020;
Published: 29 October 2020; Retracted: 27 August 2024.
Edited by:
Maria Caffo, University of Messina, ItalyReviewed by:
Xin Shang, Shandong University, ChinaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.